Zymfentra Interactions
There are 576 drugs known to interact with Zymfentra (infliximab), along with 9 disease interactions. Of the total drug interactions, 308 are major, 260 are moderate, and 8 are minor.
- View all 576 medications that may interact with Zymfentra
- View Zymfentra disease interactions (9)
Most frequently checked interactions
View interaction reports for Zymfentra (infliximab) and the medicines listed below.
- acetaminophen
- amantadine
- Apretude (cabotegravir)
- Arava (leflunomide)
- aripiprazole
- atenolol
- bisoprolol
- boron
- BuSpar (buspirone)
- calcium carbonate
- carvedilol
- Celebrex (celecoxib)
- CoQ10 (ubiquinone)
- cromolyn nasal
- dapagliflozin
- Descovy (emtricitabine / tenofovir alafenamide)
- Eliquis (apixaban)
- EpiPen (epinephrine)
- famotidine
- Farxiga (dapagliflozin)
- fexofenadine
- Fioricet with Codeine (acetaminophen / butalbital / caffeine / codeine)
- Flonase Sensimist (fluticasone nasal)
- fluvoxamine
- lisinopril
- magnesium malate
- naltrexone
- pyridostigmine
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
Zymfentra disease interactions
There are 9 disease interactions with Zymfentra (infliximab) which include:
- heart failure
- liver disease
- infections
- malignancies
- neurologic reactions
- tuberculosis
- COPD
- hematologic abnormalities
- hepatitis B
Report options
QR code containing a link to this page
More about Zymfentra (infliximab)
- Zymfentra consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
